-
Mashup Score: 55Improving Outcomes for Early-Stage NSCLC Using Targeted Therapy - 29 day(s) ago
Current research efforts in early-stage NSCLC have expanded to explore the efficacy of targeted therapy in patients with oncogenic driver mutations beyond EGFR and ALK.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 27The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast - 1 month(s) ago
Oncology and Therapy – The identification of actionable biomarkers and development of targeted therapies have revolutionized the field of lung cancer treatment. In patients with advanced non-small…
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1021st Annual Winter Lung Cancer Conference® - 3 month(s) ago
February 2-4, 2024
Source: www.gotoper.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1021st Annual Winter Lung Cancer Conference® - 3 month(s) ago
February 2-4, 2024
Source: www.gotoper.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 42Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to follow on X (Twitter) in 2023 - 5 month(s) ago
As November, the Lung Cancer Awareness Month, has just concluded, our team at OncoDaily diligently compiled a list of “Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to follow on X (Twitter) in 2023”, outstanding individuals, who are active on X (Twitter) and are significantly influencing the landscape of lung cancer.
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 39th TNM of Thymic Tumors Update - 5 month(s) ago
We present a recording of a lecture by Professor Enrico Ruffini (University of Turin, Torino, Italy) on the changes we can expect in the 9th Edition of the TNM classification for thymic epithelial…
Source: itmig.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 41Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to follow on X (Twitter) in 2023 - 5 month(s) ago
As November, the Lung Cancer Awareness Month, has just concluded, our team at OncoDaily diligently compiled a list of “Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to follow on X (Twitter) in 2023”, outstanding individuals, who are active on X (Twitter) and are significantly influencing the landscape of lung cancer.
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 37Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to follow on X (Twitter) in 2023 - 5 month(s) ago
As November, the Lung Cancer Awareness Month, has just concluded, our team at OncoDaily diligently compiled a list of “Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to follow on X (Twitter) in 2023”, outstanding individuals, who are active on X (Twitter) and are significantly influencing the landscape of lung cancer.
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6A Phase II Trial of Pevonedistat and Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer - 6 month(s) ago
Post-immunotherapy (IO) treatment options for stage IV non-small cell lung cancer (NSCLC)remain limited. Docetaxel alone or in combination with ramuci…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6A Phase II Trial of Pevonedistat and Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer - 6 month(s) ago
Post-immunotherapy (IO) treatment options for stage IV non-small cell lung cancer (NSCLC)remain limited. Docetaxel alone or in combination with ramuci…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
Check out our article featured in #ASCOdailyNews "Improving Outcomes for Early-Stage NSCLC Using Targeted Therapy" A big shout-out to Dr. Vanya Aggarwal, a second-year fellow at @LombardiCancer, for her great work @ASCO Link: https://t.co/8vemjuhdz6 https://t.co/VNPyil8Cjb